346 related articles for article (PubMed ID: 18836804)
1. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
2. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
3. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategy for patients with middle and lower third bile duct cancer.
Todoroki T; Kawamoto T; Koike N; Fukao K; Shoda J; Takahashi H
Br J Surg; 2001 Mar; 88(3):364-70. PubMed ID: 11260100
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
9. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
[TBL] [Abstract][Full Text] [Related]
12. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
[TBL] [Abstract][Full Text] [Related]
13. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
14. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
[TBL] [Abstract][Full Text] [Related]
15. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
[TBL] [Abstract][Full Text] [Related]
16. Liver metastases after curative resection in patients with distal bile duct cancer.
Takao S; Shinchi H; Uchikura K; Kubo M; Aikou T
Br J Surg; 1999 Mar; 86(3):327-31. PubMed ID: 10201773
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.
Shimada K; Sano T; Sakamoto Y; Kosuge T
Ann Surg Oncol; 2006 Dec; 13(12):1569-78. PubMed ID: 17009145
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of ductal margins in operative resection of bile duct cancer.
Higuchi R; Ota T; Araida T; Kobayashi M; Furukawa T; Yamamoto M
Surgery; 2010 Jul; 148(1):7-14. PubMed ID: 20116818
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]